These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 33328726)

  • 1. Chronic Rhinosinusitis with Nasal Polyps: Targeting IgE with Anti-IgE Omalizumab Therapy.
    Kariyawasam HH; James LK
    Drug Des Devel Ther; 2020; 14():5483-5494. PubMed ID: 33328726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Efficacy of Omalizumab in Patients with Chronic Rhinosinusitis with Nasal Polyps and Comorbid Severe Allergic Asthma.
    Atayik E; Aytekin G; Aydin İ; Omeroglu E
    Iran J Allergy Asthma Immunol; 2024 May; 23(3):245-256. PubMed ID: 39422385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omalizumab improves sinonasal outcomes in patients with chronic rhinosinusitis with nasal polyps regardless of allergic status.
    Gevaert P; Mullol J; Saenz R; Ko J; Steinke JW; Millette LA; Meltzer EO
    Ann Allergy Asthma Immunol; 2024 Mar; 132(3):355-362.e1. PubMed ID: 37951571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omalizumab for chronic rhinosinusitis.
    Brañes R; Rosenbaum A; Callejas C; Winter M
    Medwave; 2018 Nov; 18(7):e7347. PubMed ID: 30507897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials.
    Gevaert P; Omachi TA; Corren J; Mullol J; Han J; Lee SE; Kaufman D; Ligueros-Saylan M; Howard M; Zhu R; Owen R; Wong K; Islam L; Bachert C
    J Allergy Clin Immunol; 2020 Sep; 146(3):595-605. PubMed ID: 32524991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omalizumab treats chronic rhinosinusitis with nasal polyps and asthma together-a real life study.
    Bidder T; Sahota J; Rennie C; Lund VJ; Robinson DS; Kariyawasam HH
    Rhinology; 2018 Mar; 56(1):42-45. PubMed ID: 29288573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A real world study of anti-IgE monoclonal antibody in the treatment of allergic united airway disease].
    Sui HJ; Zhen Z; Wang QG; Cong TC; Huang JJ; Hu Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Feb; 57(2):273-280. PubMed ID: 36797588
    [No Abstract]   [Full Text] [Related]  

  • 8. IgE directly affects eosinophil migration in chronic rhinosinusitis with nasal polyps through CCR3 and predicts the efficacy of omalizumab.
    Yu J; Yan B; Shen S; Wang Y; Li Y; Cao F; Xiong W; Piao Y; Hu C; Sun Y; Zhang L; Wang C
    J Allergy Clin Immunol; 2024 Feb; 153(2):447-460.e9. PubMed ID: 37922997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of omalizumab in the treatment of chronic rhinosinusitis with nasal polyposis.
    Aldinger JP; Dobyns T; Lam K; Han JK
    Expert Opin Biol Ther; 2021 Sep; 21(9):1143-1149. PubMed ID: 34334061
    [No Abstract]   [Full Text] [Related]  

  • 10. Biologics in Chronic Rhinosinusitis: Current and Emerging.
    Boyd JT; Khanwalkar AR
    Immunol Allergy Clin North Am; 2024 Nov; 44(4):657-671. PubMed ID: 39389716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgE-Mediated Multimorbidities in Allergic Asthma and the Potential for Omalizumab Therapy.
    Humbert M; Bousquet J; Bachert C; Palomares O; Pfister P; Kottakis I; Jaumont X; Thomsen SF; Papadopoulos NG
    J Allergy Clin Immunol Pract; 2019; 7(5):1418-1429. PubMed ID: 30928481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Broad IgG repertoire in patients with chronic rhinosinusitis with nasal polyps regulates proinflammatory IgE responses.
    Shamji MH; Thomsen I; Layhadi JA; Kappen J; Holtappels G; Sahiner U; Switzer A; Durham SR; Pabst O; Bachert C
    J Allergy Clin Immunol; 2019 Jun; 143(6):2086-2094.e2. PubMed ID: 30763592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety of Dupilumab Versus Omalizumab in Chronic Rhinosinusitis With Nasal Polyps and Asthma: EVEREST Trial Design.
    De Prado Gomez PharmD MSc L; Khan Mbbs Mph AH; Peters Md AT; Bachert Md PhD C; Wagenmann Md M; Heffler Md PhD E; Hopkins BMBCh C; Hellings Md PhD PW; Zhang PhD M; Xing PhD J; Rowe Md P; Jacob-Nara Md Mph DHSc JA
    Am J Rhinol Allergy; 2022 Nov; 36(6):788-795. PubMed ID: 35837739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic rhinosinusitis with nasal polyps: mechanistic insights from targeting IL-4 and IL-13 via IL-4Rα inhibition with dupilumab.
    Kariyawasam HH
    Expert Rev Clin Immunol; 2020 Dec; 16(12):1115-1125. PubMed ID: 33148074
    [No Abstract]   [Full Text] [Related]  

  • 15. The Role of Biologics in the Treatment of Nasal Polyps.
    Franzese CB
    Immunol Allergy Clin North Am; 2020 May; 40(2):295-302. PubMed ID: 32278452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omalizumab versus intranasal steroids in the post-operative management of patients with allergic fungal rhinosinusitis.
    Mostafa BE; Fadel M; Mohammed MA; Hamdi TAH; Askoura AM
    Eur Arch Otorhinolaryngol; 2020 Jan; 277(1):121-128. PubMed ID: 31552526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biologics for chronic rhinosinusitis with nasal polyps.
    Bachert C; Zhang N; Cavaliere C; Weiping W; Gevaert E; Krysko O
    J Allergy Clin Immunol; 2020 Mar; 145(3):725-739. PubMed ID: 32145872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Biologics in Chronic Rhinosinusitis With Nasal Polyps.
    Patel GB; Peters AT
    Ear Nose Throat J; 2021 Jan; 100(1):44-47. PubMed ID: 33035132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omalizumab improves sleep and health status for patients with chronic rhinosinusitis with nasal polyps: An analysis of randomized clinical trials.
    Meltzer EO; Mullol J; Ko J; Saenz R; Steinke JW; Millette LA; Gevaert P
    Int Forum Allergy Rhinol; 2024 Jul; 14(7):1163-1172. PubMed ID: 38197558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local fungus-specific Immunoglobulin E production in chronic rhinosinusitis with nasal polyps.
    Ohki Y; Okamoto Y; Iinuma T; Yamamoto H; Toyotome T; Yahiro M; Yonekura S; Sakurai D; Kamei K
    Rhinology; 2020 Apr; 58(2):136-144. PubMed ID: 31904030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.